Description
Manufacturer:
Novartis India Ltd
Salt Composition:
Saroglitazar magnesium
Description:
Vymada 100mg Tab contains saroglitazar magnesium, a medication belonging to the glitazar class, primarily used in the management of dyslipidemia and type 2 diabetes mellitus. It acts as a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist.
PPAR alpha activation leads to a decrease in triglycerides and an increase in high-density lipoprotein cholesterol (HDL-C), often referred to as “good” cholesterol. PPAR gamma activation improves insulin sensitivity and helps lower blood glucose levels. In patients with diabetic dyslipidemia, Vymada helps address both high blood sugar and abnormal lipid levels, which are significant risk factors for cardiovascular diseases.
By improving lipid profile and glycemic control, saroglitazar contributes to reducing the overall cardiovascular risk in these patients. The typical dosage is 100mg once daily, but this can be adjusted by a healthcare professional based on individual patient needs and response to the medication.
It is important to take Vymada as part of a comprehensive management plan that includes diet and exercise. Potential side effects may include gastrointestinal disturbances and peripheral edema.
Regular monitoring of liver function tests and lipid profiles is usually recommended during treatment with saroglitazar. It is crucial to inform your doctor about any other medications you are taking, as drug interactions can occur. Vymada is a prescription medication and should only be used under the guidance of a qualified healthcare professional
Reviews
There are no reviews yet.